EMEA-002366-PIP01-18

Key facts

Active substance
Acetylsalicylic acid / rosuvastatin (calcium) / perindopril (tert-butylamine) / indapamide (hemihydrate)
Therapeutic area
Cardiovascular diseases
Decision number
P/0311/2018
PIP number
EMEA-002366-PIP01-18
Pharmaceutical form(s)
Capsule, hard
Condition(s) / indication(s)
Prevention of cardiovascular events
Route(s) of administration
Oral use
Contact for public enquiries
SmartGenRx Pty Ltd

Tel.  +61 (2)80524375
E-mail: arodgers@georgeinstitute.org

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating